Eosinophil infiltration into human skin is antigen-dependent in the late-phase reaction

British Journal of Dermatology

Volumn 134, Issue 6, 1996, Pages 997-1004

  Litchfield, T M ^a   Smith, C H ^a   Atkinson, B A ^a   Norris, P G ^b   Elliott, P ^b   Haskard, D O ^c   Lee, T H ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HOUSE DUST ALLERGEN; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; PRIORITY JOURNAL; SKIN INFLAMMATION; ULTRAVIOLET B RADIATION;

EID: 0029930715     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1996.tb07933.x     Document Type: Article

References (30)

1. Springer TA. Adhesion receptors of the immune system. Nature 1990; 346: 425-34.
2. Bevilacqua MP. Endothelial-leukocyte adhesion molecules. Ann Rev Immunol 1993; 11: 767-804.
3. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 1994; 76: 301-14.
4. Pober JS, Bevilacqua MP, Mendrick DL et al. Two distinct monokines, interleukin 1 and tumor necrosis factor, each independently induce the biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells. J Immunol 1986; 136: 1680-7.
5. Bevilacqua MP, Stengelin S, Gimbrone MA, Seed B. Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 1989; 243: 1160-4.
6. Springer TA, Lasky LA. Cell adhesion: Sticky sugars for selectins. Nature 1991; 349: 196-7.
7. Butcher EC. Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity. Cell 1991; 67: 1033-6.
8. Pober JS, Gimbrone MA, Lapierre LA et al. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumour necrosis factor, and immune interferon. J Immunol 1986; 137: 1893-6.
9. Diamond MS, Staunton DE, Marlin SD, Springer TA. Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation. Cell 1991; 65: 961-71.
10. Swerlick RA, Lee KH, Li L-J et al. Regulation of vascular cell adhesion molecule 1 on human dermal microvascular endothelial cells. J Immunol 1992; 149: 698-705.
11. Thornhill MH, Haskard DO. IL-4 regulates endothelial activation by IL-1. tumor necrosis factor or IFNγ. J Immunol 1990; 145: 865-72.
12. Norris P, Poston RN, Thomas DS et al. The expression of endothelial leukocyte adhesion molecule-1 (ELAM-1). intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) in experimental cutaneous inflammation: a comparison of ultraviolet-B erythema and delayed hypersensitivity. J Invest Dermatol 1991; 96: 763-70.
13. Pelletier RP, Ohye RG, Vanbuskirk A et al. Importance of endothelial VCAM-1 for inflammatory leukocytic infiltration in vivo. J Immunol 1992; 149: 2473-81.
14. Elices MJ, Osborn L, Takada Y et al. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 1990; 60: 577-84.
15. Bochner BS, Luskinskas FW, Gimbrone MAJ et al. Adhesion of human basophils, eosinophils, and neutrophils to IL-1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules. J Exp Med 1991; 171: 1553-6.
16. Kyan-Aung U, Haskard DO, Lee TH. Vascular cell adhesion molecule-1 (VCAM-1) and eosinophil adhesion to cultured human umbilical vein endothelial cells. Am Rev Respir Cell Mol Biol 1991; 5: 445-50.
17. Dobrina A, Menegazzi R, Carlos TM et al. Mechanisms of eosinophil adherence to cultured vascular endothelial cells. Eosinophils bind to the cytokine-induced endothelial ligand vascular cell adhesion molecule-1 via the very late activation antigen-4 integrin receptor. J Clin Invest 1991; 88: 20-6.
18. Weller PF, Rand TH, Goelz SE et al. Human eosinophil adherence to vascular endothelium mediated by binding to vascular cell adhesion molecule 1 and endothelial leukocyte adhesion molecule 1. Proc Natl Acad Sci USA 1991; 88: 7430-3.
19. Frew AJ, Kay AB. The relationship between infiltrating CD4+ lymphocytes, activated eosinophils, and the magnitude of the allergen-induced late phase cutaneous reaction in man. J Immunol 1988; 141: 4158-64.
20. Kyan-Aung U, Haskard DO, Poston RN et al. Endothelial leukocyte adhesion molecule-1 and intercellular adhesion molecule-1 mediate the adhesion of eosinophils to endothelial cells in vitro and are expressed by endothelium in allergic cutaneous inflammation in vivo. J Immunol 1991; 146: 521-8.
21. Leung DYM, Pober JS, Cotran RS. Expression of endothelial-leukocyte adhesion molecule-1 in elicited late phase allergic reactions. J Clin Invest 1991; 87: 1805-9.
22. Hsu SM, Raine L. Protein A, avidin and biotin in immunohistochemistry. J Histochem Cytochem 1981; 29: 1349-53.
23. Weg VB, Williams TJ, Lobb RR, Nourshargh S. A monoclonal antibody recognizing very late activation antigen-4 inhibits eosinophil accumulation in vivo. J Exp Med 1993; 177: 561-6.
24. Lundahl J, Hallden G, Hed J. Differences in intracellular pool and receptor-dependent mobilisation of the adhesion-promoting glycoprotein Mac-1 between eosinophils and neutrophils. J Leukocyte Biol 1993; 53: 336-41.
25. Morland CM, Wilson SJ, Holgate ST, Roche WR. Selective eosinophil leukocyte recruitment by transendothelial migration and not by leukocyte-endothelial cell adhesion. Am J Respir Cell Mol Biol 1992; 6: 557-66.
26. Baggiolini M, Dahinden CA. CC chemokines in allergic inflammation. Immunol Taday 1994; 15: 127-33.
27. Kameyoshi Y, Dorschner A, Mallet AI et al. Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J Exp Med 1992; 176: 587-92.
28. Dahinden CA, Geiser T, Brunner T et al. Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine. J Exp Med 1994; 179: 751-6.
29. Meurer R, van Riper G, Feeney W, et al. Formation of eosinophlic and monocyte intradermal inflammatory sites in the dog by injection of human RANTES hut not human monocyte chemoattractant protein 1, human macrophage inflammatory protein 1 alpha, or human interleukin 8. J Exp Med 1993; 178: 1913-21.
30. Jose PJ, Griffiths-Johnson DA, Collins PD et al. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J Exp Med 1994; 179: 881-7.